NIH-funded research NIH-funded research

Developing models to understand infectious diseases.

Official title: Pre-Clinical Models of Infectious Diseases

Funded at Sigmovir Biosystems, INC. · NIH-11197679 · Data updated 2026-11-12

This study is working on building models that mimic infectious diseases to help us learn more about how they work and find better treatments, which could ultimately help patients like you get improved care and prevention options.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSigmovir Biosystems, INC.
NIH-funded
Lab location1 site (Rockville, United States)
Project startJuly 15, 2024
Project endJuly 14, 2031
Funding year2024
Award (this year)$2,500
NIH project number75N93024D00020-0-759302400001-1
Project IDNIH-11197679 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of infectious diseases or those who may benefit from new therapeutic approaches.

Less likely to help

Patients with non-infectious diseases or those who are not at risk for infectious diseases may not receive any benefit from this research.

What this research studies

This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and potential treatments. By utilizing advanced modeling techniques, the research aims to identify effective medical countermeasures against various infectious agents. Patients may benefit from insights gained through these models, which could lead to improved therapies and preventive measures for infectious diseases.

Why it matters

Potential benefit: If successful, this research could lead to the development of new treatments and preventive strategies for infectious diseases.

How similar studies have gone: Previous research has shown success in developing pre-clinical models for infectious diseases, indicating that this approach is both tested and promising.

Where this research is happening

  • Sigmovir Biosystems, INC.
    Rockville, United States
    Active

Related research

Other NIH-funded projects on the same topics.

  • Evaluating vaccines and treatments for respiratory viruses using cotton rats.

    This study is looking at how well new vaccines and treatments for respiratory syncytial virus (RSV) work by testing them on cotton rats first, so we can make sure they're safe and effective for people later on.

    NIH research Sigmovir Biosystems, INC. · Rockville, United States · NIH-11250878

  • Developing antibodies to study immune cells in cotton rats.

    This study is all about developing special tools to help scientists see and understand how different immune cells work in cotton rats, which can be really helpful for learning more about diseases.

    NIH research Sigmovir Biosystems, INC. · Rockville, United States · NIH-11191835

  • Targeting a protein to reduce lung injury caused by viral infections.

    This study is looking at a new way to help people with lung injuries and breathing problems caused by viral infections, like COVID-19, by blocking a protein that makes inflammation worse, with the hope of improving their lung function.

    NIH research Sigmovir Biosystems, INC. · Rockville, United States · NIH-11163178

  • Drugs that activate RXR and PPARγ to reduce virus-related lung injury

    This project tests whether activating two cellular receptors (RXR and PPARγ) can push immune cells toward healing and reduce lung damage after viral infections like flu or RSV.

    NIH research Sigmovir Biosystems, INC. · Rockville, United States · NIH-11158766

  • Investigating new treatments for lung injury caused by viruses

    This study is looking at how special immune cells in your lungs respond to viral infections that can cause serious breathing problems, and it aims to find new ways to help heal your lungs if you have conditions like ARDS.

    NIH research Sigmovir Biosystems, INC. · Rockville, United States · NIH-10952071

  • Targeting a protein to reduce lung injury caused by viral infections.

    This study is looking at a new treatment to help people with serious lung problems caused by viral infections, like COVID-19, by blocking a specific protein that makes inflammation worse, and it's being tested in models that act like human conditions.

    NIH research Sigmovir Biosystems, INC. · Rockville, United States · NIH-10917056

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.